Thomas Idorn

Company: Novo Nordisk

Job title: International Medical Vice President

Seminars:

REMODEL: Understanding the Kidney-Specific Mode of Action Using Novel Technologies 10:30 am

Mechanistic, exploratory trials in clinical drug development Combining novel methodologies for a holistic understanding of the MoA The concept of kidney biopsies for research purpose • Applying Single-Cell RNA-Seq to Correlate Particular Genes to Certain Mechanistic PathwaysRead more

day: Day 2 Track 1 AM